Vico Therapeutics

Gene therapy company developing treatments for rare neurological diseases using antisense oligonucleotide (ASO) technology, with a focus on spinocerebellar ataxias and other CNS disorders.

Location
Leiden, Netherlands
Founded
2017
Investors
1
Categories
biotech, gene-therapy, rare-disease, antisense, neurology

Investors

NameLocationTypeStagesPortfolio
Polaris PartnersUSbiotech-focused-33